Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 367,012 | 361,992 | 355,085 | 331,914 | 342,488 |
| Marketable Securities | 19,832 | 25,821 | 32,770 | 52,916 | 72,715 |
| Receivables | 150,540 | 151,428 | 146,581 | 140,279 | 131,227 |
| Inventories | 26,748 | 24,457 | 23,214 | 20,320 | 24,156 |
| Other current assets | 11,722 | 8,308 | 9,157 | 9,312 | 8,239 |
| TOTAL | $596,019 | $590,241 | $584,203 | $573,896 | $596,812 |
| Non-Current Assets | |||||
| PPE Net | 94,103 | 93,038 | 92,158 | 87,865 | 92,012 |
| Intangibles | 862,447 | 870,808 | 879,170 | 887,530 | 895,894 |
| Other Non-Current Assets | 85,469 | 87,024 | 87,746 | 91,048 | 96,511 |
| TOTAL | $1,042,019 | $1,050,870 | $1,059,074 | $1,066,443 | $1,084,417 |
| Total Assets | $1,638,038 | $1,641,111 | $1,643,277 | $1,640,339 | $1,681,229 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 200,777 | 200,424 | 200,073 | N/A | N/A |
| Accounts payable and accrued liabilities | 21,607 | 16,514 | 17,186 | 18,336 | 20,334 |
| Accrued Expenses | 75,067 | 75,163 | 68,154 | 52,743 | 68,230 |
| Other current liabilities | 409 | 589 | 972 | 1,144 | 2,130 |
| TOTAL | $301,241 | $296,406 | $289,959 | $76,710 | $96,304 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 412,948 | 413,724 | 414,419 | 616,729 | 619,103 |
| TOTAL | $434,458 | $436,495 | $437,434 | $640,219 | $643,388 |
| Total Liabilities | $735,699 | $732,901 | $727,393 | $716,929 | $739,692 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 128,461 | 128,361 | 128,158 | 127,712 | 127,610 |
| Common Shares | 128 | 128 | 128 | 127 | 127 |
| Retained earnings | -325,781 | -310,457 | -292,758 | -274,116 | -247,055 |
| Other shareholders' equity | -206 | -643 | -1,022 | -1,330 | -1,674 |
| TOTAL | $902,339 | $908,210 | $915,884 | $923,410 | $941,537 |
| Total Liabilities And Equity | $1,638,038 | $1,641,111 | $1,643,277 | $1,640,339 | $1,681,229 |